TwinBeech Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,525
Closed -$884K 716
2025
Q4
$884K Sell
3,525
-26,196
-88% -$6.96M 0.06% 319
2025
Q3
$8.53M Buy
+29,721
New +$7.96M 0.34% 93
2025
Q2
Sell
-152,851
Closed -$35.6M 845
2025
Q1
$35.6M Buy
+152,851
New +$37.1M 0.65% 40
2022
Q4
Sell
-63,880
Closed -$11.2M 826
2022
Q3
$11.2M Buy
+63,880
New +$13.1M 0.3% 102
2022
Q2
Sell
-31,163
Closed -$7.06M 619
2022
Q1
$7.06M Buy
+31,163
New +$7.33M 0.31% 95
2021
Q4
Sell
-2,064
Closed -$499K 699
2021
Q3
$499K Buy
+2,064
New +$520K 0.04% 432

Other funds holding LH

TwinBeech Capital's LH Position: Q1 2026 in Review

TwinBeech Capital sold out of Labcorp (LH) in Q1 2026, closing a stake of 3,525 shares — an estimated $884K sold.

TwinBeech Capital first reported a position in LH in Q3 2021 and held it in 6 quarters. The position peaked at $35.6M in Q1 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • TwinBeech Capital reported no remaining Labcorp position as of Q1 2026 after selling out during the quarter.
  • TwinBeech Capital sold 3,525 Labcorp shares in Q1 2026, an estimated $884K.
  • TwinBeech Capital first reported a position in Labcorp in Q3 2021 and held it in 6 quarters.
  • TwinBeech Capital's Labcorp position peaked at $35.6M in Q1 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on TwinBeech Capital's 13F filing for Q1 2026, filed 15 May 2026.